Novo Nordisk Shares Slide 8.27% Over Three Days Amid Technical Bearish Signals
Generated by AI AgentAinvest Technical Radar
Tuesday, Jun 17, 2025 7:01 pm ET2min read
NVO--
Novo Nordisk (NVO) declined 3.47% to $74.34 in the most recent session, marking its third consecutive daily loss with an 8.27% cumulative decline over this period. This price action occurs within a broader technical context characterized by conflicting signals between bearish momentum indicators and emerging oversold conditions, warranting a multi-indicator assessment.
Candlestick Theory
The three-day decline formed three consecutive bearish candles with progressively lower closes ($79.83 → $77.02 → $74.34) – a pattern resembling Three Black Crows. This suggests persistent selling pressure following the recent peak at $81.44 on 2025-06-12. Immediate support is observed near $74.14 (2025-06-17 low), aligning with the psychological $74 level. Resistance is firm at $78.38 (2025-06-16 high), reinforced by the $79.92-$81.44 consolidation zone from mid-June. A decisive break below $74.14 may expose the $72.00-$72.65 support area from early June.
Moving Average Theory
The 50-day SMA (approximated at $76.80) and 100-day SMA (∼$78.20) both slope downward, reflecting deteriorating intermediate momentum. The current price trades below these averages, confirming near-term bearish control. Longer-term sentiment remains guarded as the 200-day SMA (∼$86.50) hovers well above the spot price, though its positive slope persists. A sustained recovery would need to reclaim the 50-day SMA, now acting as dynamic resistance.
MACD & KDJ Indicators
MACD (12-26-9) resides in negative territory with the signal line above the MACD histogram – a configuration signaling bearish momentum. Concurrently, KDJ oscillators reflect oversold extremes: K-line dipped below 20 and the stochastic %D nears 15. While MACD’s bearish alignment suggests further downside risk, KDJ’s deeply oversold state implies increased vulnerability to a corrective bounce. This divergence between trend (MACD) and momentum (KDJ) creates conflicting short-term signals.
Bollinger Bands
Bands expanded notably during the three-day sell-off, indicating volatility surge. Price breached the lower band ($75.10 estimate) on 2025-06-17, closing near this boundary ($74.34). Historically, such deviations often precede short-term mean reversion, though extended breaks below the lower band can persist in strong downtrends. Watch for band contraction or a price close back inside the bands to signal stabilization. The 20-day SMA ($77.25) anchors the structure as resistance.
Volume-Price Relationship
Down days consistently exhibited elevated volume (avg. 7.77M shares vs. 30-day avg. ∼7.5M), validating bearish conviction. However, volume on the most recent decline ($74.34 close) was lower than during the June 10 rally (13.08M shares). This divergence suggests waning selling intensity near the $74 support. Sustainability of further downside would require volume expansion; failure to do so may undermine bearish momentum.
Relative Strength Index (RSI)
The 14-day RSI (∼28.5) entered oversold territory (<30), reaching its lowest level since mid-May. While this signals extreme downward momentum, oversold RSI readings during established downtrends – like the current 50-day SMA breakdown – can persist. Traders should treat this as a warning of potential exhaustion rather than an immediate reversal signal. A move above RSI 35 would be the first indication of bearish fatigue.
Fibonacci Retracement
Using the swing low of $64.04 (2025-05-12) and high of $81.44 (2025-06-13), key retracements are:
38.2% → $74.79 | 50.0% → $72.74 | 61.8% → $70.69.
Price recently breached the 38.2% level ($74.79) and hovers near it. Confluence exists here with horizontal support at $74.14 and the psychological $74 mark. The 50% retracement ($72.74) represents the next critical support, aligning with the June 5 low ($72.32). Bearish momentum would strengthen on a sustained break below $72.74.
Confluence and Divergence Observations
Confluence at $74.00-$74.80 (38.2% Fibonacci, psychological level, June 17 low) makes this a pivotal support zone. Divergences include oversold KDJ/RSI readings conflicting with bearish MACD and moving average alignments, while volume patterns lack conviction at current support. A failure to hold $74.00-$74.80 may accelerate declines toward the 50% Fibonacci ($72.74) and 61.8% ($70.69) levels. Conversely, a volume-supported rebound above $76.62 (June 16 low) could relieve immediate pressure and challenge the 50-day SMA.
Novo Nordisk (NVO) declined 3.47% to $74.34 in the most recent session, marking its third consecutive daily loss with an 8.27% cumulative decline over this period. This price action occurs within a broader technical context characterized by conflicting signals between bearish momentum indicators and emerging oversold conditions, warranting a multi-indicator assessment.
Candlestick Theory
The three-day decline formed three consecutive bearish candles with progressively lower closes ($79.83 → $77.02 → $74.34) – a pattern resembling Three Black Crows. This suggests persistent selling pressure following the recent peak at $81.44 on 2025-06-12. Immediate support is observed near $74.14 (2025-06-17 low), aligning with the psychological $74 level. Resistance is firm at $78.38 (2025-06-16 high), reinforced by the $79.92-$81.44 consolidation zone from mid-June. A decisive break below $74.14 may expose the $72.00-$72.65 support area from early June.
Moving Average Theory
The 50-day SMA (approximated at $76.80) and 100-day SMA (∼$78.20) both slope downward, reflecting deteriorating intermediate momentum. The current price trades below these averages, confirming near-term bearish control. Longer-term sentiment remains guarded as the 200-day SMA (∼$86.50) hovers well above the spot price, though its positive slope persists. A sustained recovery would need to reclaim the 50-day SMA, now acting as dynamic resistance.
MACD & KDJ Indicators
MACD (12-26-9) resides in negative territory with the signal line above the MACD histogram – a configuration signaling bearish momentum. Concurrently, KDJ oscillators reflect oversold extremes: K-line dipped below 20 and the stochastic %D nears 15. While MACD’s bearish alignment suggests further downside risk, KDJ’s deeply oversold state implies increased vulnerability to a corrective bounce. This divergence between trend (MACD) and momentum (KDJ) creates conflicting short-term signals.
Bollinger Bands
Bands expanded notably during the three-day sell-off, indicating volatility surge. Price breached the lower band ($75.10 estimate) on 2025-06-17, closing near this boundary ($74.34). Historically, such deviations often precede short-term mean reversion, though extended breaks below the lower band can persist in strong downtrends. Watch for band contraction or a price close back inside the bands to signal stabilization. The 20-day SMA ($77.25) anchors the structure as resistance.
Volume-Price Relationship
Down days consistently exhibited elevated volume (avg. 7.77M shares vs. 30-day avg. ∼7.5M), validating bearish conviction. However, volume on the most recent decline ($74.34 close) was lower than during the June 10 rally (13.08M shares). This divergence suggests waning selling intensity near the $74 support. Sustainability of further downside would require volume expansion; failure to do so may undermine bearish momentum.
Relative Strength Index (RSI)
The 14-day RSI (∼28.5) entered oversold territory (<30), reaching its lowest level since mid-May. While this signals extreme downward momentum, oversold RSI readings during established downtrends – like the current 50-day SMA breakdown – can persist. Traders should treat this as a warning of potential exhaustion rather than an immediate reversal signal. A move above RSI 35 would be the first indication of bearish fatigue.
Fibonacci Retracement
Using the swing low of $64.04 (2025-05-12) and high of $81.44 (2025-06-13), key retracements are:
38.2% → $74.79 | 50.0% → $72.74 | 61.8% → $70.69.
Price recently breached the 38.2% level ($74.79) and hovers near it. Confluence exists here with horizontal support at $74.14 and the psychological $74 mark. The 50% retracement ($72.74) represents the next critical support, aligning with the June 5 low ($72.32). Bearish momentum would strengthen on a sustained break below $72.74.
Confluence and Divergence Observations
Confluence at $74.00-$74.80 (38.2% Fibonacci, psychological level, June 17 low) makes this a pivotal support zone. Divergences include oversold KDJ/RSI readings conflicting with bearish MACD and moving average alignments, while volume patterns lack conviction at current support. A failure to hold $74.00-$74.80 may accelerate declines toward the 50% Fibonacci ($72.74) and 61.8% ($70.69) levels. Conversely, a volume-supported rebound above $76.62 (June 16 low) could relieve immediate pressure and challenge the 50-day SMA.

If I have seen further, it is by standing on the shoulders of giants.
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet